Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia
Clinical trial NCT05851027 · COMPLETED
Trial details
- NCT number
- NCT05851027
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2021-09-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.